Treatment of Nonmotor Symptoms in Parkinson's Disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International review of neurobiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/bs.irn.2017.03.002PMID 28554415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid

  2018cited by this paper
• Training Neurodegenerative Disease Support Group Leaders: A New Support Group Functioning Scale

  2018cited by this paper
• Conditionally Essential Nutrients: The State of the Science

  2018cited by this paper
• LPS induces dopamine depletion and iron accumulation in substantia nigra in rat models of Parkinson's disease.

  2018cited by this paper
• A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

  2017cited by this paper
• Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management.

  2017cited by this paper
• The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence

  2017cited by this paper
• Nonmotor features of Parkinson's disease subtypes

  2016cited by this paper
• Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations.

  2016cited by this paper
• New concepts in the pathogenesis and presentation of Parkinson's disease.

  2016cited by this paper
• L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room.

  2016cited by this paper
• Open-Label Study of Sleep Disturbances in Patients with Parkinson’s Disease Treated with Rasagiline

  2016cited by this paper
• Non motor subtypes and Parkinson's disease.

  2016cited by this paper
• Prevalence of anxiety in Parkinson's disease: A systematic review and meta‐analysis

  2016cited by this paper
• Mild cognitive impairment in Parkinson's disease is improved by transcranial direct current stimulation combined with physical therapy

  2016cited by this paper
• Detecting depression in Parkinson disease

  2016cited by this paper
• Antidepresivos en la enfermedad de Parkinson. Recomendaciones del grupo de trastornos del movimiento de la Asociación Madrileña de Neurología

  2016cited by this paper
• Deep brain stimulation and sleep-wake functions in Parkinson's disease: A systematic review.

  2016cited by this paper
• Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording

  2016cited by this paper
• Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.

  2016cited by this paper
• The Impact of Physical Activity on Non-Motor Symptoms in Parkinson’s Disease: A Systematic Review

  2016cited by this paper
• Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments

  2016cited by this paper
• Gut dysfunction in Parkinson's disease.

  2016cited by this paper
• Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle.

  2016cited by this paper
• Neuropsychiatric Issues in Parkinson’s Disease

  2016cited by this paper
• Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease.

  2016cited by this paper
• Neurourology and Urodynamics 35 : 551 – 563 ( 2016 ) A Guideline for the Management of Bladder Dysfunction in Parkinson ’ s Disease and Other Gait Disorders

  2016cited by this paper
• Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis.

  2016cited by this paper
• Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis.

  2015cited by this paper
• New clinical trials for nonmotor manifestations of Parkinson's disease

  2015cited by this paper
• Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson’s disease

  2015cited by this paper
• The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease

  2015cited by this paper
• Droxidopa for the Short‐Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)

  2015cited by this paper
• Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms

  2015cited by this paper
• Orthostatic Hypotension: Mechanisms, Causes, Management

  2015cited by this paper
• Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease.

  2015cited by this paper
• Management of constipation in Parkinson’s disease

  2015cited by this paper
• A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson’s disease patients

  2015cited by this paper
• Constipation preceding Parkinson's disease: a systematic review and meta-analysis

  2015cited by this paper
• EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

  2015cited by this paper
• Neuropsychiatric Symptoms in Parkinson’s Disease

  2015cited by this paper
• Parkinson disease: Unravelling the nonmotor mysteries of Parkinson disease

  2015cited by this paper
• Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.

  2015cited by this paper
• Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.

  2015cited by this paper
• Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study

  2015cited by this paper
• Electroconvulsive Therapy Intervention for Parkinson's Disease.

  2015cited by this paper
• Droxidopa for neurogenic orthostatic hypotension

  2014cited by this paper
• Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa

  2014cited by this paper
• New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's disease

  2014cited by this paper
• Dairy foods intake and risk of Parkinson’s disease: a dose–response meta-analysis of prospective cohort studies

  2014cited by this paper
• Bladder function of patients with Parkinson's disease

  2014cited by this paper
• Microsubthalamotomy improves sleep in patients affected by advanced Parkinson's disease.

  2014cited by this paper
• Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

  2014cited by this paper
• Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.

  2014cited by this paper
• Depression and anxiety following deep brain stimulation in Parkinson's disease: systematic review and meta-analysis.

  2014cited by this paper
• Management of orthostatic hypotension in patients with Parkinson's disease

  2014cited by this paper
• Nonmotor symptoms and health‐related quality of life in early Parkinson's disease

  2014cited by this paper
• Systematic review with meta‐analysis: highly selective 5‐HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation

  2014cited by this paper
• Non-motor symptoms: the core of multi-morbid Parkinson's disease.

  2014cited by this paper
• Dose–response meta‐analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease

  2014cited by this paper
• Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease

  2013cited by this paper
• Nonmotor fluctuations in Parkinson disease

  2013cited by this paper
• Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease -- a randomized study.

  2013cited by this paper
• The Management of Orthostatic Hypotension in Parkinson’s Disease

  2013cited by this paper
• Evolution of mild cognitive impairment in Parkinson disease

  2013cited by this paper
• Coenzyme Q10 deficiency in patients with Parkinson's disease.

  2012cited by this paper
• Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence

  2012cited by this paper
• Psychosocial Interventions for Depression and Anxiety in Parkinson's Disease

  2012cited by this paper
• Caffeine for treatment of Parkinson disease

  2012cited by this paper
• Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease

  2012cited by this paper
• Habitual intake of dietary flavonoids and risk of Parkinson disease

  2012cited by this paper
• Cognitive Behavioral Therapy for Depression and Anxiety in Parkinson's Disease: A Clinical Review

  2012cited by this paper
• Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder.

  2011cited by this paper
• Parkinson's disease sleep scale—validation of the revised version PDSS‐2

  2011cited by this paper
• Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease

  2011cited by this paper
• Chronic Subcutaneous Infusion Therapy with Apomorphine in Advanced Parkinson's Disease Compared to Conventional Therapy: A Real Life Study of Non Motor Effect

  2011cited by this paper
• Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

  2011cited by this paper
• Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis.

  2011cited by this paper
• The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

  2011cited by this paper
• Use of probiotics for the treatment of constipation in Parkinson's disease patients.

  2011cited by this paper
• Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

  2011cited by this paper
• Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, pLacebo-Controlled Study (RECOVER)

  2010cited by this paper
• Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

  2010cited by this paper
• Preventing and treating orthostatic hypotension: As easy as A, B, C

  2010cited by this paper
• Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.

  2010cited by this paper
• Best practice guide for the treatment of REM sleep behavior disorder (RBD).

  2010cited by this paper
• Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open‐label study

  2009cited by this paper
• Glutathione and Parkinson's disease: is this the elephant in the room?

  2008cited by this paper
• Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.

  2008cited by this paper
• Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

  2008cited by this paper
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

  2008cited by this paper
• Effects of Ropinirole on Nonmotor Symptoms of Parkinson Disease: A Prospective Multicenter Study

  2008cited by this paper
• Agents for Treatment of Overactive Bladder: A Therapeutic Class Review

  2007cited by this paper
• [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].

  2007cited by this paper
• Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease

  2007cited by this paper
• The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study

  2007cited by this paper
• Prospective study of dietary pattern and risk of Parkinson disease.

  2007cited by this paper
• International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

  2006cited by this paper
• Non-motor symptoms of Parkinson's disease: diagnosis and management.

  2006cited by this paper
• Subthalamic nucleus deep brain stimulation does not alter long-term heart rate variability in Parkinson’s disease

  2006cited by this paper

• Exploring the Manifestation of Non-motor Symptoms in Parkinson's Disease in a Tertiary Care Center: A Comprehensive Analysis

  2025cites this paper
• Vortioxetine Attenuates Rotenone-Induced Enteric Neuroinflammation via Modulation of the TLR2/S100B/RAGE Signaling Pathway in a Rat Model of Parkinson's Disease.

  2025cites this paper
• Effect of hyperbaric oxygen therapy for non-motor symptoms among patients with Parkinson's disease: A systematic review and meta-analysis

  2025cites this paper
• Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications.

  2024cites this paper
• Impact of deep brain stimulation on urogenital function in Parkinson’s disease: a systematic review and meta-analysis

  2024cites this paper
• Efficacy of acupuncture for the treatment of Parkinson’s disease-related constipation (PDC): A randomized controlled trial

  2023cites this paper
• Rehabilitation for non-motor symptoms for patients with Parkinson's disease from an α-synuclein perspective: a narrative review.

  2023cites this paper
• Sleep disturbance in caregivers of individuals with Parkinsonism: a systematic review and meta-analysis

  2022cites this paper
• Probabilistic Neural Network-based Model for Identification of Parkinson’s Disease by using Voice Profile and Personal Data

  2021cites this paper
• Impact of Subthalamic Deep Brain Stimulation on Hyposmia in Patients With Parkinson's Disease Is Influenced by Constipation and Dysbiosis of Microbiota

  2021cites this paper
• Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents

  2021cites this paper
• Prevalence of Non‐Motor Symptoms and Non‐Motor Fluctuations in Parkinson's Disease Using the MDS‐NMS

  2020cites this paper
• Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson’s Animal Model

  2020cites this paper
• Decreased Striatal Vesicular Monoamine Transporter Type 2 Correlates With the Nonmotor Symptoms in Parkinson Disease.

  2019influential citation
• The Diagnosis and Management of Parkinson ’ s Disease Article Information

  2019cites this paper
• The Locus coeruleus in Parkinson’s disease - from basic research to new translational perspectives -

  2019cites this paper
• Suicide in Parkinson's disease: A systematic review.

  2019cites this paper
• Parkinson's disease: A Review about Pathogenesis, Pharmaceutical Treatment and Experimental Models

  2018cites this paper
• Training Neurodegenerative Disease Support Group Leaders: A New Support Group Functioning Scale

  2018cites this paper
• LPS induces dopamine depletion and iron accumulation in substantia nigra in rat models of Parkinson's disease.

  2018cites this paper
• Training Leaders of Neurodegenerative Disease Support Groups: Development of a Support Group Well-Being Measure

  2017cites this paper